Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDfs Furniture Plc Regulatory News (DFS)

Share Price Information for Dfs Furniture Plc (DFS)

Share Price is delayed by 15 minutes
Get Live Data
120.50    -0.50 (-0.41%)
Bid:
120.00
Ask:
121.00
Spread: 1.00 (0.833%)
Market Cap: £278.97m
DFS Live PriceLast checked at - London Stock Exchange

Intraday Dfs Furniture Plc Share Chart

Trading Statement

17 Jul 2025 07:00

RNS Number : 3752R
DFS Furniture PLC
17 July 2025
 

17 July 2025

 

Immediate release

 

DFS Furniture plc ("DFS" and the "Group")

 

2025 FULL YEAR TRADING UPDATE

 

Strong trading and good cost control resulting in PBT(A) slightly above the top end of guidance

 

DFS Furniture plc, the market leading retailer of upholstered furniture in the United Kingdom, today issues the following trading update for the 52 week year ending 29 June 2025 ("FY25").

 

Summary:

Full year PBT(A)1 is expected to be slightly above the top end of guidance (£25-29m) and up around £20m year on year

Profit performance driven by strong trading, gross margin rate progression and continued cost discipline

Strong H1 trading performance continued in the second half. H2 Group order intake +10% year on year2 (in line with the growth achieved in H1), demonstrating significant outperformance of the market that remains subdued

● Financial position has further strengthened. Net bank debt reduced to around £107m (FY24 year end £165m) and leverage3 further reduced to around 1.4x (FY24 year end 2.5x)

 

Trading overview:

The Group traded consistently through the period, with order intake up +10% year on year2 in both H1 and H2, supported by volume and average order value growth. Both of our retail brands performed well, with DFS up +8.7% and Sofology up +16.2% year on year2 due to successful implementation of our growth initiatives. Our proprietary data shows the Group has grown market share in the specialist upholstery sector4 in a period where the market remained subdued.

 

Gross sales, which are recognised on delivery of orders to customers, were up +5.8% year on year. This is lower than the level of order intake growth (which is measured on a 52 week vs 52 week basis) due to a shift in customer orders to ranges with longer lead times and the impact of the prior year being a 53 week financial reporting period. Consequently, the Group enters FY26 with a resilient order bank.

 

We have maintained our focus on disciplined cost management and continued to improve our gross margins. This approach, in combination with the increase in gross sales, has resulted in expected year on year PBT(A)1 growth slightly above the top end of our guidance (£25m-£29m), up from £10.5m (FY24).

 

The Group's financial position has improved with net bank debt (excluding capitalised leases) reducing in the period to around £107m (FY24 year end £165m) and leverage3 reducing to around 1.4x (FY24 year end 2.5x) as we target a return to our 0.5x-1.0x target range.

 

The Group will announce its full year results for the period ending 29 June 2025 on 25 September 2025.

 

Comment from Tim Stacey, Group Chief Executive

"We are pleased to report that we expect profit for the full year to be slightly above the top end of our guidance. Our excellent first half performance set the foundation for our success, with strong trading through the rest of the year with both our DFS and Sofology brands outperforming the market. We have continued to maintain a strong focus on disciplined cost management and improved our gross margins, leading to significant year on year profit growth. In addition, cash flow was healthy and our balance sheet is strengthening as we progress towards our target leverage range.

 

Whilst the macro environment remains challenging our business is in great shape and I would like to thank our amazing colleagues for their support and commitment as we relentlessly focus on delivering against our strategy together. Looking forward, we are confident that the Group is well positioned to drive attractive returns for shareholders as the market recovers and we remain focused on delivering our medium term ambition of £1.4bn revenue and 8% PBT margins."

 

1 PBT(A): Underlying profit before tax and brand amortisation

2 Full year order intake growth measured on a 52 week vs 52 week basis was 10.2%.

To avoid the distorting impact caused by a different number of winter sale trading days in each trading period H1 YoY order intake growth (+10.1%) has been measured using weeks 1-25 of each trading period. H2 YoY (+10.3%) has been measured using the most comparable 27 weeks.

FY24 was a 53 week reporting period, order intake growth measured on a 52 vs 53 week basis is 8.7% year on year.

3 Banking covenant IAS17 definition

4 Proprietary banking data covering 13 specialist upholstery retailers

 

Enquiries:

 

DFS (enquiries via Teneo)

Tim Stacey (Group CEO)

Marie Wall (Interim CFO)

Phil Hutchinson (Investor Relations)

investor.relations@dfs.co.uk

 

Teneo

James Macey-White

Ayo Sangobowale

+44 (0)20 7353 4200

85fs.dfs@teneo.com

 

About DFS Furniture plc

 

The Group is the clear market-leading retailer of upholstered furniture in the United Kingdom. Our Group purpose is to bring great design and comfort into every living room, in an affordable, responsible and sustainable manner. We operate an integrated physical and digital retail network of living room furniture showrooms and web sites in the United Kingdom and Republic of Ireland, trading through our leading brands, DFS and Sofology. We attract customers through our targeted and national marketing activities and our reputation for high quality innovative products and services, breadth of product offer and favourable consumer financing options. We fulfil orders for our exclusive product ranges through our own UK finished goods factories, and through manufacturing partners located in the UK, Europe and Far East, and delivered with care through our expert final-mile delivery service "The Sofa Delivery Company Limited".

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFRDAIRLIE
Date   Source Headline
20th May 20264:31 pmRNSHolding(s) in Company
6th May 20267:00 amRNSDirectorate change
30th Apr 20267:00 amRNSPurchase of shares by Employee Benefit Trust
1st Apr 20263:06 pmRNSEBT Update
19th Mar 20267:00 amRNSInterim Results
20th Jan 20267:00 amRNSTrading Statement
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSTotal Voting Rights
8th Dec 20251:40 pmRNSTotal Voting Rights
17th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Nov 20254:17 pmRNSDirectorate change
14th Nov 20253:47 pmRNSResult of AGM
14th Nov 20257:00 amRNSAGM Trading Statement
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
23rd Oct 20251:19 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSDirector/PDMR Shareholding
20th Oct 202510:35 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSDirector/PDMR Shareholding
14th Oct 20257:00 amRNSAnnual Financial Report
25th Sep 20257:00 amRNSFY25 Preliminary Results
12th Aug 20258:00 amRNSDirector Declaration
17th Jul 20257:00 amRNSTrading Statement
13th May 202511:59 amRNSHolding(s) in Company
10th Apr 202512:46 pmRNSInvestor Presentation via Investor Meet Company
9th Apr 202511:29 amRNSDirectorate Change
4th Apr 202510:37 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSInterim Results
24th Feb 20257:00 amRNSDirectorate Change
12th Feb 20251:15 pmRNSChange of Adviser
7th Feb 20253:14 pmRNSHolding(s) in Company
5th Feb 20259:28 amRNSHolding(s) in Company
29th Jan 20257:00 amRNSDirectorate Change
17th Jan 20257:00 amRNSTrading Statement
8th Jan 202512:05 pmRNSHolding(s) in Company
7th Jan 202512:34 pmRNSHolding(s) in Company
6th Jan 20252:47 pmRNSHolding(s) in Company
3rd Jan 20252:17 pmRNSHolding(s) in Company
13th Dec 20247:00 amRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSHolding(s) in Company
27th Nov 20247:00 amRNSValidation of SBTi Targets
25th Nov 202411:52 amRNSHolding(s) in Company
25th Nov 202410:57 amRNSHolding(s) in Company
22nd Nov 20243:31 pmRNSResult of AGM
22nd Nov 20247:00 amRNSTrading Update and Directorate Change
19th Nov 20249:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.